100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada
logo-home
Buscado previamente por ti
Buscado previamente por ti
logo
Antiviral Chemistry & Chemotherapy’s current antiviral agents FactFile (2nd edition): DNA viruses $8.49   Añadir al carrito
Navegar rápidamente a
Vista previa
  2.  
  3. Chemistry
  4.  
  5. Chemistry

Examen

Antiviral Chemistry & Chemotherapy’s current antiviral agents FactFile (2nd edition): DNA viruses
 11 vistas  0 veces vendidas
  • Grado
  • Chemistry
  • Institución
  • Chemistry

Antiviral Chemistry & Chemotherapy’s current antiviral agents FactFile (2nd edition): DNA viruses Hugh J Field1 * and Erik De Clercq2 1Department of Veterinary Medicine, University of Cambridge, Cambridge, UK 2Rega Institute for Medical Research, Leuven, Belgium *Corresponding author: E-m...

[Mostrar más]

Vista previa 2 fuera de 12  páginas

Información del documento

  • 26 de julio de 2024
  • 12
  • 2023/2024
  • Examen
  • Preguntas y respuestas

Temas

  • antiviral chemistry
  • chemotherapys
  • antiviral

Escuela, estudio y materia

  • Chemistry
  • Chemistry
Todos documentos para esta materia (2188)

Vendedor

avatar-seller
scottgrades

Comentarios recibidos

Vista previa del contenido

© 2008 International Medical Press 51Antiviral Chemistry & Chemotherapy ’s current antiviral agents FactFile (2nd edition): DNA viruses
Hugh J Field1* and Erik De Clercq2 1Department of Veterinary Medicine, University of Cambridge, Cambridge, UK 2Rega Institute for Medical Research, Leuven, Belgium
*Corresponding author: E-mail: AVCCtracker@intmedpress.com
Although most of the recent attempts to develop new antiviral agents have been focussed on RNA viruses (in particular, HIV and hepatitis C virus), a few new c ompounds are now awaiting their entry into the field of DNA v iruses, particularly poxviruses, such as variola virus, because of the bioterrorist context, and herpesviruses, such a s herpes simplex virus and cytomegalovirus, where the market scene has for many years been dominated by acyclovir, pen ciclovir and ganciclovir and their respective orally bioavailable prodrugs: valaciclovir, famciclovir and valganciclo vir. Here, we review the current ‘state of the art’ with old c ompounds ready to rotate off and new compounds eagerly awaiting to appear on the continuously evolving scene of antiviral drug development.
Key to FactFile
StructureSystematic/other names
NotesCompany/Institution
References: xxx,xxxCompound name
Proprietary name
Abbreviation list
BCNA Bicyclic nucleoside analogue CMV cytomegalovirus EBV Epstein–Barr virus FIV feline immunodeficiency virus HBV hepatitis B virus HCMV human cytomegalovirus HHV human herpes virus HPV human papillomavirus HSV herpes simplex virus
NRTI nucleoside reverse transcriptase inhibitorNtRTI nucleotide reverse transcriptase inhibitorSIV simian immunodeficiency virus VZV varicella-zoster virusAntiviral Chemistry & Chemotherapy 19:51–62 Factfile: DNA viruses
© 2008 International Medical Press 52HN
N H2NO
NN
OHO9-(2-Hydroxyethoxymethyl)guanine, acycloguanosine, aciclovir.
Principal target virus : HSV-1, HSV-2, VZV.
Other activities : HCMV, EBV.
Compound class : Acyclic nucleoside analogue.
Clinical stage : Licensed. Patent expired.
The compound is used for the treatment of mucosal, cutaneous and systemic HSV-1 and HSV-2 infections (including HSV encephalitis and genital herpes), an d in VZV infections (including herpes zoster ophthalmicus). It is also used for the prophylaxis of HSV infections (genital herpes) and VZV infections. Extremely safe compound may be used for long-term suppressive therapy. Still regarded as ‘gold standard’ for HSV therapy. Rather poor oral availability; the oral prodrug is valaciclovir.GlaxoSmithKline (GSK)
References: 1–3Acyclovir
Zovirax®
N
NN
N
O PO
HO
OHNH29-[2-(Phosphonylmethoxy)ethyl]adenine, PMEA, GS 393. Principal target virus : HBV.
Other activities : HIV-1, HIV-2, HCMV, HSV-1, HSV-2, FIV, SIV.
Compound class : NtRTI (acyclic nucleoside phosphonate).
Used as its oral prodrug, adefovir dipivoxil, in the treatment of chronic HBV infections.Gilead Sciences
References: 1,4,5Adefovir
N O
N
CH3SN
SNH2
OOCH3N-[5-aminosulfonyl)-4-methyl-1,3-thiazol-2yl)-N-methyl-[4-(2-pyridinyl)
phenyl]acetamide.
Principal target virus : HSV-1, HSV-2.
Mode of action : Inhibits HSV helicase-primase complex. Compound class: Thiazolylsulfonamide
Developed originally by Bayer Company. An extremely active and specific inhibitor of HSV-1 and HSV-2, which has been shown efficacious in a variety of infection models.
Resistance mutations found most frequently in helicase and occasionally in primase genes. Mechanism appears to differ slightly from BILS 22BS.AiCuris
References: 6–8BAY 57-1293

Los beneficios de comprar resúmenes en Stuvia estan en línea:

Garantiza la calidad de los comentarios

Garantiza la calidad de los comentarios

Compradores de Stuvia evaluaron más de 700.000 resúmenes. Así estas seguro que compras los mejores documentos!

Compra fácil y rápido

Compra fácil y rápido

Puedes pagar rápidamente y en una vez con iDeal, tarjeta de crédito o con tu crédito de Stuvia. Sin tener que hacerte miembro.

Enfócate en lo más importante

Enfócate en lo más importante

Tus compañeros escriben los resúmenes. Por eso tienes la seguridad que tienes un resumen actual y confiable. Así llegas a la conclusión rapidamente!

Preguntas frecuentes

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

100% de satisfacción garantizada: ¿Cómo funciona?

Nuestra garantía de satisfacción le asegura que siempre encontrará un documento de estudio a tu medida. Tu rellenas un formulario y nuestro equipo de atención al cliente se encarga del resto.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller scottgrades. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for $8.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

45,681 summaries were sold in the last 30 days

Founded in 2010, the go-to place to buy summaries for 14 years now

Empieza a vender
$8.49
  • (0)
  Añadir